Yew Bio-Pharm Group, Inc. reported earnings results for the third quarter and revenue results for the nine months ended September 30, 2013. Total revenue rose 12.5% to $1.54 million from $1.37 million for the 2012 third quarter; Operating profit was $0.91 million, compared with $1.14 million in the year-ago quarter. Net income was $0.77 million, or $0.01 per diluted share, compared with $0.82 million, or $0.02 per diluted share, in 2012 third quarter.

Total revenue was $5.45 million for the first nine months, compared with $4.8 million for the same period last year as a result of a solid start at the beginning of the year.